Patents by Inventor J. Patten

J. Patten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12003467
    Abstract: During web browsing, a plurality of web entities associated with browsing activity of a first browsing identity of a first user are received. One or more of the plurality of web entities are selected for sharing. Further, one or more subscriber browsing identities associated with the first browsing identity are selected based on one or more associated trust relationships, and the selected web entities are sent to the selected subscriber browsing identities. The disclosure enhances social interaction and collaborative aspects of web browsing with respect to web browsing activity, enabling users to share browsing activity easily.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: June 4, 2024
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Swathi Ganapathi, George Karalis, Michael J. Patten
  • Patent number: 10626158
    Abstract: The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: April 21, 2020
    Assignee: Corning Incorporated
    Inventors: Na Li, Jie Wang, Christopher J. Patten
  • Patent number: 10629064
    Abstract: The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: April 21, 2020
    Assignee: Corning Incorporated
    Inventors: Na Li, Jie Wang, Christopher J. Patten
  • Patent number: 10503371
    Abstract: A Web application displays Web content in a user interface (UI) tab having multiple associated virtual tabs. The multiple associated virtual tabs can include a visible tab hosting Web content that is currently visible, one or more hidden tabs each hosting Web content that is not currently visible, and optionally one or more empty tabs each hosting no Web content or only primitive Web content. For each hidden tab, the Web content hosted in the hidden tab is suspended, which refers to ceasing execution of instructions in and/or other operations performed by the Web content. For example, audio/video playback is paused, execution of script instructions ceases, and so forth.
    Type: Grant
    Filed: April 4, 2017
    Date of Patent: December 10, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Jacob S. Rossi, Michael J. Patten, Michael J. Ens
  • Publication number: 20190263885
    Abstract: The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.
    Type: Application
    Filed: May 9, 2019
    Publication date: August 29, 2019
    Inventors: Na Li, Jie Wang, Christopher J. Patten
  • Publication number: 20190263884
    Abstract: The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.
    Type: Application
    Filed: May 9, 2019
    Publication date: August 29, 2019
    Inventors: Na Li, Jie Wang, Christopher J. Patten
  • Patent number: 10336806
    Abstract: The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: July 2, 2019
    Assignee: Corning Incorporated
    Inventors: Na Li, Jie Wang, Christopher J. Patten
  • Patent number: 10336805
    Abstract: The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: July 2, 2019
    Assignee: Corning Incorporated
    Inventors: Na Li, Jie Wang, Christopher J. Patten
  • Patent number: 10282475
    Abstract: Systems, methods and computer program products are described herein that collect and analyze data generated by embedded systems included within a user's devices to generate recommendations for presentation to the user within the context of the user's web browser. The recommendations may comprise, for example, suggested information resources and/or search queries. Such recommendations may be presented to the user as part of a new tab page or within an address bar of the web browser's graphical user interface. In accordance with further embodiments, the user device data is used by a search engine to generate search results, and/or a ranking of search results.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: May 7, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Michael J. Patten, Ritika Kapadia
  • Patent number: 10209880
    Abstract: Various embodiments provide a travel log for manipulation of content. In at least some embodiments, the travel log can be presented as a visual element of a web browser and can enable a user to navigate through visited content (e.g., web pages) via manipulation of the content using touch-based and/or touchless gestures. Implementations can facilitate navigation through content by representing the travel log as a visual “time line” of visited content that can be scrolled via manipulation through a web browser user interface. For example, a user can navigate the travel log to older content by manipulating the travel log in one direction, and can navigate the travel log to newer content by manipulating the travel log in a different direction.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: February 19, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Michael J. Patten, Paul Armistead Hoover, John Wesley Terrell, Nicholas R. Waggoner
  • Publication number: 20180343215
    Abstract: During web browsing, a plurality of web entities associated with browsing activity of a first browsing identity of a first user are received. One or more of the plurality of web entities are selected for sharing. Further, one or more subscriber browsing identities associated with the first browsing identity are selected based on one or more associated trust relationships, and the selected web entities are sent to the selected subscriber browsing identities. The disclosure enhances social interaction and collaborative aspects of web browsing with respect to web browsing activity, enabling users to share browsing activity easily.
    Type: Application
    Filed: May 25, 2017
    Publication date: November 29, 2018
    Inventors: Swathi GANAPATHI, George KARALIS, Michael J. PATTEN
  • Publication number: 20180265563
    Abstract: The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.
    Type: Application
    Filed: May 24, 2018
    Publication date: September 20, 2018
    Inventors: Na Li, Jie Wang, Christopher J. Patten
  • Publication number: 20180265562
    Abstract: The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.
    Type: Application
    Filed: May 24, 2018
    Publication date: September 20, 2018
    Inventors: Na Li, Jie Wang, Christopher J. Patten
  • Patent number: 10047136
    Abstract: The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: August 14, 2018
    Assignee: Corning Incorporated
    Inventors: Na Li, Jie Wang, Christopher J. Patten
  • Patent number: 10017558
    Abstract: The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: July 10, 2018
    Assignee: Corning Incorporation
    Inventors: Na Li, Jie Wang, Christopher J. Patten
  • Patent number: 9996622
    Abstract: Systems, methods and computer program products are described that enable a web browser to automatically determine that a user thereof is logged into an enterprise network and, based on at least this determination, present the user with a new tab page or similar interface that includes features that facilitate access by the user to enterprise-related content. The enterprise-related content may include, for example, enterprise-related web sites, content shared by colleagues, content trending among team members, documents that the user recently worked on, enterprise-related news, and industry-related news.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: June 12, 2018
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Sean O. Lyndersay, Martin J. Hall, Michael J. Patten, Joshua T. Stickler
  • Patent number: 9886430
    Abstract: Methods, systems, apparatuses, and computer program products are provided for selecting content on a displayed page. A selection mode may be initiated with regard to a displayed document that includes content. The initiation of the selection mode may be detected. Multiple entities in the displayed document are determined, with each entity including a portion of the content of the document. The displayed document is annotated to indicate the determined entities. Content selected by a user in the displayed document may be detected. At least one entity is determined to be associated with the selected content. The determined associated entity/entities are indicated in the displayed document as active entities. The user is enabled to refine the set of active entities. An action is enabled to be performed on the active entities.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: February 6, 2018
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Michael J. Patten, Joon Chang
  • Patent number: 9880693
    Abstract: Enabling creation of a user-specific storyboard style based on a storyboard edited by a user. Metadata defined by analyzing the editing decisions made by the user and the media content associated with the storyboard represents the user-specific style. The user-specific style may be applied to other media content to produce a fully edited storyboard that matches the style of the example storyboard from which the user-specific style was created. The produced storyboard is combined with the other media content to produce audio/video data for consumption by the user.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: January 30, 2018
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Randolph Bruce Oakley, Michael J. Patten, Andrew Kutruff, Russell Scott Randall
  • Publication number: 20170355745
    Abstract: The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.
    Type: Application
    Filed: August 29, 2017
    Publication date: December 14, 2017
    Inventors: Na Li, Jie Wang, Christopher J. Patten
  • Publication number: 20170355746
    Abstract: The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.
    Type: Application
    Filed: August 29, 2017
    Publication date: December 14, 2017
    Inventors: Na Li, Jie Wang, Christopher J. Patten